Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05309421 |
| Title | Study of EVX-01 Vaccine in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Evaxion Biotech A/S |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Melanoma Institute Australia | RECRUITING | Wollstonecraft | New South Wales | 2065 | Australia | Details |
| Ballarat Health Services (Grampians Health) | RECRUITING | Ballarat Central | Victoria | 3350 | Australia | Details |
| One Clinical Research | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |
| Sir Charles Gairdner Hospital | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |